is million probably Good people people you, and to country Hello, everyone. evening. unfortunately forward. gradual Last a that spoke the and and as can we tomorrow. number filed had can by things XX going for double normal as I’m go unemployment thank we expect recovery adjust optimistic to up lives
there and people the doing of we've that can out death without. diabetes, significant higher The more to considering and be who possible with with everything been customers people a elevated insulin forward ever. than as as the plus one goal now us control need with seen a get rate for to into discussion injectable go not has those as COVID diabetes the are we go and This hospital AXc our discussion million goal they around X the are
us control webinars weeks. get the our life, and freedom weeks several team for to than we've dozen the medical about marketing with we been last their life the has sales people over talk as and live six our and team ever to continue done more that is Hence commercial over mission health to more focused their control to and the human. This last
higher we've of quarterly the in in on March. COVID achieved XX% $X here over event U.S. despite Really quickly QX first quarter I want touch of was XXXX AFREZZA key early million happening the revenue things as to we and $X.X some scripts increased could up of $XXX,XXX highest by million of the and net month approximately revenue we've was had There March. accelerating stocking during of to-date. patient to quarter sales the wholesaler stock that see
-- a million ranged certainly ranges QX. see $X.X However, estimates with we from research million. $X.X million consensus to beat of in $X.X here have analysts And you can can consensus
of more Our each is gross it quarter a high over record positive achieved to five quarters from grow and the continued XX% negative historically. margin a last margin up gross
product the Brazil Additionally, Brazil not down continue in their unfortunately only to get prices lockdown can down launched We COVID ship They slowing and in them at different to cost get of reduced sales this the moving BM we in a there market. come under are June their them currencies how markets wrong on we what's with going can we as understand that second talk shipment and launching ensure occurred, the that get as time September, help anticipate in and but progress. weekly out a supply to their through surely succeed. we the have to well shutting too
like million Fortunately, we the the we receive open were last in third additional path path milestone up brief study to markets have end on do on FDA QX. don't on had slightly, critical – are to earnings United any week $XX.X they're the COVID-XX track submission the again. impact as to be the and and and of track Therapeutics on to now to delayed critical our the trials expect they whilst And to or call we – the we commit our timeline and not They look in year. of the don't
which protocols the have patients PK are that finish humanly BREEZE are the factor space, UT and up the remaining summer. I study we the additional again that go. has job making to a as will open quickly done trials the great possible study over and study when ready and believe up enroll the as markets we sure human other to two
good we've versus you million flow reduce million that cash at burn the this more On continued shortly, news XXXX. front, $XX.X quarter-over-quarter, and $XX.X in will Steve year to the share with cash
happy with our growth am few and forward. past moves our see the quarters that to I Overall, continued over team excited
cash We the the continue in. tightly we to company manage new our environment that in – running
– doing keep safe to implemented We've has move talk environment. had work done I'm our significantly. about home. slightly it's to to incredible going enhanced how COVID. patients and company and since our and a entire from what safe. response restrictions Number been switch as travel is virtual everyone job early to an amazed an one, smoothly over How work COVID-XX is our team to employees what asking, is March. two We've much we're three pretty communications The
read everyone's at and shutdown can working or wake their think they as call hours o'clock I X a o'clock to zoom to at more up at night emails. they X before start X
product to process occurs our as saving The supply will that carry goods ensure chain. is in the limited remainder finished supply only of our essential from Afrezza. producing working in maintain XXXX facility We two supply the to we life home. manufacturing We're maintain need Number staff marketplace. to no us of with disruption personnel the of Danbury remaining the
of the healthcare a Hospital. donation strain to provider in system by Danbury want in-person reduce at we visits. minimizing mask We've Additionally, made medical the
in. opportunities to We find support our continue local communities that to we operate
developing able I point, one recently. because not In we the opportunities FDA or require inhalation that terms won't an pursuing we OTC powder, capacity XX a of talked because would cartridges likely them of is two it's that current four XX At treatments solution. second feasible times three of one to evaluated day, which this product, a COVID-XX, about four our not be decided to just in for regulations. to probably is, it And forward move we
forward. we products other under the or we these evolves two I'll whether investigation. to move watch this marketplace are remain see continue There that as and not
of and opportunities – to partners these. outside opportunity will said fund happy to these we're But we're personnel and opportunities not around our to we our shareholder lot infrastructure we previously, on fund As seek invest dedicate COVID-XX. a going money
as we hopeful comes partners yes, find we could an we've vaccine inhalable optimistic before need that make vaccine, the one that. of the we like But vaccine flu. to still too get available the on the to seen with be like I'm anything
that In spend our business and addition, really through reduces mostly, in it's the on we our important QX activities, sustain reducing year. which here
QX helped vendors employees receive the We the by quarter our help of cost were or here to paycheck year. preserve own have XX% cuts part majority for Many either taking the forward by of program jobs which pay structure in of protection we reduced out in our QX fees remainder we our their and starting the us reduce went for us as QX. and lucky here this
were week But starts into weeks blue March the with can Number me these peak NRx Let trend see a some here the the patient downward on February a of going marketplace. been one, always between TRx first the these the share and off going April March and the that insights new of on line. funds. we lag you usually of and seven and is first through really you over had the in we as received when tracking into week last
and treatments we down hopefully the to me be happened we to build are are to back TRx saw are in force our May, stabilize true NBRx and considering you QX remarkably brand early QX is looks products start can get retention that of as Patient it almost into not to up impacted demand new see in out up things due But get which well to sales start held that going lack our there. through April. XX% that in
We release to each office. received up in those happening, are the on getting are as insights the the we they're train sales next being week we you week going opened back I anecdotally from seven and customers open these isn’t our out our feedback marketplace week and just employees into reps as how up positive to our things marketplace expect that territories this again force tell welcome waves of what's feedback using to we'll can up. as continue
We're our temperatures that exposed sure guidelines to equipment. follow housekeeping sure cause we COVID-XX. We're we don't and checking employees using to make are any for contamination customary protection making good cross
new go stabilization we to more I where assuming week, go the out out access changes states drive hopefully next and get the in help into and weeks see we coming in forward close that to expect to us start QX. week, as this we'll all our there's as start are June reps will These and things go no We XX up. opening growth think
with Afrezza. from where a private feedback the take reps is we're practice have to getting far the customers doctors are continue of the so disproportionate amount sales news good we and into the our that smaller We
academic We in centers practices are are that based seeing se. limited large welcoming and per academic health more
something butter, there we'll while new continue places are to and safe. that's watch are not get continue we’ll those as bread where in to to to some and there and patient occur get starts try far as possible that's and So our we
in the are saw. not there, to those Overall of also I And industry. negatively the and it's we had acuity impacted. out healthcare new many, down of NBRx have may market disruptive you want the impact on launches freely across starts of So COVID-XX a trends that's the who for some the seen parts system of new way been many have market downloadable. talk report some about
we're are XX%, telehealth depending treatment generally XX% today's starts to and new changing is not least or down on in world interactions that patient not a specialty Patient at for up but lot, the normal facing. regimens,
a As as into with telehealth being want help bigger manage they don't I see marketplace. to out live go to continues this opportunity the to persist, people diabetes
April a other day May. to the as On Afrezza, significantly states starts fills increased, and fills for we've the XX here across NRx in and but we seen but we've And the talked mail softness in timing, not marketplace as March. We've in XX-day forward seen hopefully seen pull order. actually more with flatten out here slightly disease about
one, these What to model we've via have we Number a care can interactions mitigate that implemented now with effective HCP’s virtual we done zoom. activities? have
Mchats COVID-XX, that something to leader. one doctors topics last leaders to We a that putting allow thought and continue XX out webinars there, day, call every customers getting week. thought had time We're to engage today, one us around we a and on couple have week. Afrezza and different we're we XXX one one-on-one listening telemedicine. with And talk We to host that at
center focused help can increase as on every bridge moving as free where also patients four Our them possible. go to our is claims believe seeing early of claims signs converted paid but be our XX% weeks to pay to claims go forward. into as customer continue forward. We're we XX% some We're to experience continuing that we we
unemployment. here We're help have continuity to care the also patients ensure despite
for drug and a sure to should free any provide can make $XX. that program up four patient startup program that than have doesn't We commercial copay system’s months more pay
of is do the report have pharmacy our QX pharmacies, major XX% don't and understand to network what We that all launched Symphony. now that our and show up expect as We we to sales. make specialty impact scripts in to these weekly any almost
starting these directly minimize to have Additionally, the great patients a one we've new ACVX and device, of we of implemented factor patients Afrezza to an can disruption making ship program where any [ph] patient sure starts. moving can
XX launch on in for roles protocol predict we We're commercial from later this for business. will our pandemic year. we a expect we hub we planning said, We QX success. are QX. FDA and new the That and impact that finalizing we can't events of we in near-term that that expand disrupted with plan pediatric fill overall investing our medical ultimate efforts and impact reimbursement back the in in for an support have While been are QX, unfavorable a
we're So can't the can. our best trying predict as while control destiny we future, we to
I'm to it to turn over going Steve.
